Simplify Exchange Traded Funds - Simplify High Yield PLUS Credit Hedge ETF (CDX) Stock Price

22.91 ▲ +0.06 (+0.26%)
Open: 22.85 Vol: 142.6K Day's range: 22.805 - 22.927 Sep 30, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
CDX Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL BUY SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 22.85▼ 22.85▼ 22.85▼ 22.87▲ 22.89▲
MA10 22.85▼ 22.84▼ 22.85▼ 22.90▲ 22.97▼
MA20 22.85▼ 22.84▲ 22.86▼ 22.88▲ 23.04▼
MA50 22.89▼ 22.89▼ 22.88▼ 22.96▼ 22.90▲
MA100 22.89▼ 22.89▼ 22.87▼ 23.03▼ 23.01▼
MA200 22.88▼ 22.89▼ 22.94▼ 22.86▲ N/A    
  5 mins 30 mins Hourly Daily Weekly
MACD 0.004▲ 0.003▲ 0.002▲ 0.004▲ -0.026▼
RSI 44.787▼ 44.876▼ 44.621▼ 50.104▲ 48.194▼
STOCH 71.429     55.794     44.655     52.684     27.063    
WILL %R -71.429     -86.667▼ -44.828     -43.750     -67.692    
CCI -23.810     -56.281     24.969     -23.744     -68.888    
Latest Filters Detected On CDX
RSI $CDX RSI(14) Crossed Above 50 Set Alert
MA $CDX Price Crossed Above MA(200) Set Alert
MA $CDX Price Crossed Above MA(26) Set Alert
MA $CDX Price Crossed Above MA(13) Set Alert
MA $CDX Price Crossed Above MA(7) Set Alert
Simplify Exchange Traded Funds - Simplify High Yield PLUS Credit Hedge ETF News
Why Guardant Health (GH) Stock Is Trading Up Today
Monday, September 29, 2025 09:15 AM
What Happened? Shares of diagnostics company Guardant Health (NASDAQ:GH) jumped 1.6% in the morning session after the U.S. Food and Drug Administration (FDA) approved its Guardant360® CDx blood test ...
Guardant Health gets FDA nod for Guardant360 CDx as a companion diagnostic
Monday, September 29, 2025 08:13 AM
Guardant Health (NASDAQ:GH) has received approval from the U.S. FDA for its Guardant360 CDx, which serves as a companion diagnostic tool. The Guardant360 CDx is specifically approved for use alongside ...
FDA Approves Guardant360® CDx as Companion Diagnostic for Eli Lilly and Company’s Inluriyo™ (imlunestrant) for Treatment of ESR1-mutated Advanced Breast Cancer
Monday, September 29, 2025 05:19 AM
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that the U.S. Food and Drug Administration (FDA) has approved its Guardant360® CDx as a companion diagnostic ...
CDX historical stock data
date open high low close volume
30/09/25 22.85 22.927 22.805 22.91 142,600
29/09/25 22.80 22.905 22.80 22.85 118,300
26/09/25 22.85 22.864 22.76 22.85 207,100
25/09/25 22.85 22.85 22.73 22.78 169,400
24/09/25 23.05 23.05 22.93 22.97 191,967
23/09/25 22.89 23.00 22.89 23.00 89,900
22/09/25 22.96 23.00 22.90 22.97 151,764
19/09/25 22.94 22.97 22.86 22.93 138,700
18/09/25 22.94 22.94 22.80 22.85 197,100
17/09/25 22.93 22.93 22.79 22.88 101,882
Quote Details
52wk Low:21.57
52wk High:24.89
Vol:142.6K
Avg Vol(3m):5.2M
1Y Chng:-1.88%
1M Chng:-0.09%
Add to Watch List
More Information
Sector N/A
Index N/A
Market Cap. 0.00